Alpegiani Marco

Title: Alpegiani Marco: Innovator in Pharmaceutical Chemistry

Introduction

Alpegiani Marco is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as topoisomerase I inhibitors. His work has implications for cancer treatment, showcasing the importance of innovation in medical research.

Latest Patents

Marco holds a patent for "Camptothecins with a modified lactone ring." This patent describes compounds of formula (I) or (II), where the groups are defined in the detailed description. The patent includes racemic mixtures, individual enantiomers, individual diastereoisomers, their mixtures, and pharmaceutically acceptable salts. These compounds are recognized for their role as topoisomerase I inhibitors, which are crucial in cancer therapy.

Career Highlights

Throughout his career, Marco has worked with prominent organizations in the pharmaceutical industry. Notably, he has been associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and the Istituto Nazionale per lo Studio e la Cura dei Tumori. His experience in these institutions has allowed him to contribute to significant advancements in cancer research and treatment.

Collaborations

Marco has collaborated with esteemed colleagues, including Mauro Marzi and Maria Ornella Tinti. These partnerships have fostered a collaborative environment that enhances the innovation process in pharmaceutical development.

Conclusion

Alpegiani Marco's contributions to pharmaceutical chemistry, particularly through his patent on camptothecins, highlight the vital role of inventors in advancing medical science. His collaborations and career achievements reflect a commitment to improving cancer treatment through innovative research.